Peter Gundermann
Analyst · CJS Securities
Thank you, Debbie, and good morning, everybody. Thanks for tuning into our call. Our agenda, as usual, we'll start off with a summary on our quarter and some of the developments that we're seeing in the market. Dave will pry through the numbers, both on the income statement and the balance sheet. And then I'll take it back and talk about our revised forecast for the topline for the second half of the year, and then we'll close with Q&A, as usual. So a summary of the quarter. Revenue was lighter than our first quarter. It was about where we, actually, expected it to be. It compared well to last year with adjusted sales up 5.4%. The adjustment, of course, I'm assuming some knowledge here, but in the first quarter we sold our semiconductor test business. So most of the numbers that we are going to be talking about today are adjusted numbers, excluding the effects of that semiconductor test business, both from the current periods and from the comparable periods. I'll try to make that clear as we go through. But that -- the good assumption is you're listening to the call. So revenue adjusted was about a $187 million, up 5% from last year's second quarter, and both the segments contributed to the growth. It is down, sequentially, from first quarter when we had a very strong revenue of $205 million. For the year, our adjusted sales are up 12% to $392 million, again, both the segments contributing. The lower volume from the first quarter to the second quarter did put the pressure on margins. Our adjusted net income for the second quarter was similar to last year at 3.4% of sales, but well down from first quarter's 7.9%. For the year, so far, our adjusted net income is 5.7%, double what it was last year for the first six months. Dave is going to go through the numbers in more detail, but I thought I'd some time on the major issues that we're seeing and facing, that are influencing our perspective and influencing our numbers. One is, we continue to see pretty strong tariff cost, unfortunately. The second quarter, our tariff charges were $2.3 million, year-to-date through 6 months, they come in the $4 million. In the second quarter, also, we faced some pretty strong restructuring cost, especially in our Test segment. As the Test segment adjusted to lace after semiconductor test. The total charge for that restructuring cost in the quarter was $2.2 million, that restructuring, we expect, will face somewhere around $8 million to $9 million on an annual basis going forward, beginning in the current quarter, the third quarter of 2019. We've talked quite a bit in recent periods about our 3 stragglers or 3 struggling businesses. In the second quarter, those businesses had a collective operating loss of $7.7 million, that is well above the $5 million that we predicted. And there is some good news here and some unexpected bad news. The good news is that 2 of the 3 businesses, we have very strong line of sight to resolution. A resolution in this case is getting them at or near in the neighborhood of breakeven, and those 2 are CCC and Armstrong. Both have predictable quarters and both have a path, we feel, forward to get to -- approaching breakeven by year-end, such that we won't plan on talking about these 2 in this context afterwards. The third one, AeroSat, had a setback in the quarter. And that is our ambitions for our tail-mount business jet connectivity system, which we are taking the market with a couple of partners had a step back when one of the critical satellites, used to make up the system, failed and went out of orbit, and has, basically, been lost. And that in turn has resulted in the team deciding to put sales on hold, until replacement capacity that's suitable in nature both from a cost and a performance standpoint can be developed. Realistically, we don't expect that to happen towards the very end of the year at the earliest. So AeroSat did not get on the path that we expected. Of the $7.7 million collective loss for the Group, AeroSat drove 70% of it. And with this delay in the tail-mount program our path towards breakeven is, significantly, complicated. Basically, we are on hold till we get later this year and figure out what the options are with the satellite network that we're going to use for the system going forward. Additionally, we've seen some programs slides in the market, including the 737 MAX, which is the favorite topic for everybody in the industry these days. It's become clear at quarter we're on that the reduced production rates would be continued longer than we originally expected. We started the year at 52, well it's a lump, we thought we're going to be down around 40 to 42 starting, say in, April till about June and July. And then we go back to 52 and then up to the goal of 58 kind of towards the end of the year. But as of now, it appears that, that lower production rate will go on indefinitely, with the hope of going up towards the end of the year. We have about $85,000 direct to Boeing on the 37 and another $10,000 that goes through other customers to get on the airplane. And so the cumulative drop in the production estimates, as we understand it right now, comes to about a $10 million revenue drop over the course of the year. With all that on us, our bookings for the quarter were $170 million, that's a relatively low level compared to what we have seen in recent years. To some extent that, maybe, shouldn't be a surprise because we've had very strong quarters for the last 3 or 4 quarters, leading up to this quarter. So maybe, it was just break in the action. But there is some evidence that with the MAX grounding, the airline industry, in general, has tight capacity, tight capacity means that the airlines are very reluctant to take their aircraft down for upgrades. And upgrades are, essentially, what much of our IFE and IFEC sales are all about. So we've seen some evidence of some airlines that are particularly MAX dependent, that they want to delay their programs until the MAX situation is resolved. And we, obviously, don't have any information on that beyond what everybody else has in the industry. But at this point, the MAX situation is clearly an evolving scenario. So those are my overall color comments, to begin the summary of the quarter. I'll turn it on -- turn it over to Dave to follow through some of the numbers.